One Equity Partners completes sale of Systagenix to KCI

November 7, 2013

De Brauw Blackstone Westbroek has assisted private-equity firm One Equity Partners on its EUR 485 million divestment of Systagenix, an established provider of advanced wound-care products based in the United Kingdom, to Kinetic Concepts, Inc. (KCI).

The acquisition of Systagenix enhances KCI’s position as a leading provider of transformational healing solutions with a diverse product portfolio dedicated to advancing the practice of medicine and improving the lives of patients around the world.


Senior associate Niels Geuze: ‘We have a long and excellent relationship with One Equity Partners. Working with them on the KCI transaction was again a very enjoyable and interesting experience. In addition to advising on the Dutch law aspects of the sale, we coordinated a pre-closing restructuring of Systagenix involving some fifteen jurisdictions. This matches well with De Brauw’s strategy: to be the trusted adviser of our clients, both nationally and internationally, in any jurisdiction, with the assistance of local counsel as needed.’ 


René Clumpkens (lead partner)

We keep track of you on our site with cookies, in order to offer the basic functionality of the website and generate user statistics on an anonymous basis to make our website more user-friendly. We do not use or share your data with third parties for advertising purposes.